Assessment report for GLP-1 based therapies as adopted by the CHMP

Withdrawal Assessment report for Jenzyl, INN: RIDAFOROLIMUS

This withdrawal Assessment Report is based on the latest assessment report adopted by the CHMP with all information of a commercially confidential nature deleted. This should be read in conjunction with the “Questions and Answers” document on the withdrawal of the application: the Assessment Report may not include all available information on the product if the CHMP assessment of the latest sub...

SINEREM, INN: superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate

International Nonproprietary Name (INN): superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate Day 180 Assessment Report as adopted by the CHMP with all information of a commercially confidential nature deleted. This should be read in conjunction with the " Question and Answer " document on the withdrawal of the application: the Assessment Report may not include ...

Guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease

Draft agreed by Efficacy Working Party June 2007 Adopted by CHMP for release for consultation 19 July 2007 End of consultation (deadline for comments) 31 January 2008 Agreed by Efficacy Working Party July 2008 Adopted by CHMP 24 July 2008 Date for coming into effect 1 February 2009 Updated draft agreed by CNS Working Party June 2012 Adopted by CHMP 21 June 2012 Start of public consultation n/a ...

Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk

Adopted by CHMP 15 November 2007 Date for coming into effect 31 May 2008 Draft agreed by Cardiovascular Working Party 28 March 2012 Adopted by CHMP for release for consultation 14 May 2012 Start of public consultation 30 May 2012 End of consultation (deadline for comments) 30 November 2012 Agreed by Cardiovascular Working Party 27 March 2013 Adopted by CHMP 30 May 2013 Date for coming into effe...

Refusal Chmp Assessment Report for Rhucin